Nalaganje...
CRISPR/Cas9‐mediated double knockout of SRPK1 and SRPK2 in a nasopharyngeal carcinoma cell line
BACKGROUND: Serine‐arginine protein kinase (SRPK) is a regulator of alternative splicing events via phosphorylation of splicing factor proteins. Oncogenic roles of SRPK1 and SRPK2 have been reported in various types of cancer. To date, only SRPK1/2 specific inhibitors and small interfering RNA (siRN...
Shranjeno v:
| izdano v: | Cancer Rep (Hoboken) |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7941449/ https://ncbi.nlm.nih.gov/pubmed/32671994 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cnr2.1224 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|